Evidence map›Paper›PMID 37796769›Full record

ArticlePloS one2023

Functional analysis of Collagen 17a1: A genetic modifier of junctional epidermolysis bullosa in mice.

Thomas J Sproule, Robert Y Wilpan, Benjamin E Low, Kathleen A Silva, Deepak Reyon, J Keith Joung, Michael V Wiles, Derry C Roopenian, John P Sundberg

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. HMCN1 variants aggravate epidermolysis bullosa simplex phenotype.The Journal of experimental medicine · 2025
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Thomas J SprouleThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0002-7937-232X
Robert Y WilpanThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Benjamin E LowThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0003-0350-4602
Kathleen A SilvaThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Deepak ReyonMolecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
J Keith JoungMolecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
Michael V WilesThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0002-3620-8386
Derry C RoopenianThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
John P SundbergThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0002-1523-5430
Jackson Laboratory · USHarvard University · US

Funding

CRE Driver Strain ResourcesR24OD011190 · OD · JACKSON LABORATORY · PI MURRAY, STEPHEN A, SMITH, CYNTHIA LOUISE · 2012 to 2022
$7.9M
ADVANCING ZINC FINGER NUCLEASES FOR TARGETED GENOME MANIPULATIONR01GM088040 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI JOUNG, J. KEITH, PETERSON, RANDALL T · 2009 to 2016
$4.5M
Advancing stem cell technologies using engineered zinc finger proteinsDP1GM105378 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI JOUNG, J. KEITH · 2012 to 2014
$2.6M
NIGMS NIH HHS DP1 GM105378NIGMS NIH HHS R01 GM088040NIH HHS R24 OD011190
6 · The paper itself

Abstract

Previous work strongly implicated Collagen 17a1 (Col17a1) as a potent genetic modifier of junctional epidermolysis bullosa (JEB) caused by a hypomorphic mutation (Lamc2jeb) in mice. The importance of the noncollagenous domain (NC4) of COLXVII was suggested by use of a congenic reduction approach that restricted the modifier effect to 2-3 neighboring amino acid changes in that domain. The current study utilizes TALEN and CRISPR/Cas9 induced amino acid replacements and in-frame indels nested to NC4 to further investigate the role of this and adjoining COLXVII domains both as modifiers and primary risk effectors. We confirm the importance of COLXVI AA 1275 S/G and 1277 N/S substitutions and utilize small nested indels to show that subtle changes in this microdomain attenuate JEB. We further show that large in-frame indels removing up to 1482 bp and 169 AA of NC6 through NC1 domains are surprisingly disease free on their own but can be very potent modifiers of Lamc2jeb/jeb JEB. Together these studies exploiting gene editing to functionally dissect the Col17a1 modifier demonstrate the importance of epistatic interactions between a primary disease-causing mutation in one gene and innocuous 'healthy' alleles in other genes.

Indexed as

Epidermolysis Bullosa, JunctionalAmino AcidsAnimalsCollagenMiceMutationNon-Fibrillar CollagensAmino AcidsCollagenNon-Fibrillar Collagens

Identifiers

PMID37796769
PMCPMC10553217
OpenAlexW4387378909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.